Cargando…
MRI Features of Hepatic Sarcomatoid Carcinoma Different From Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
INTRODUCTION: Hepatic sarcomatoid carcinoma (HSC) is a rare type of liver cancer with a high malignant grade and poor prognosis. This study compared the clinical characteristics and magnetic resonance imaging (MRI) features of HSCs with those of hepatocellular carcinoma (HCC) and intrahepatic cholan...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8247642/ https://www.ncbi.nlm.nih.gov/pubmed/34221954 http://dx.doi.org/10.3389/fonc.2021.611738 |
_version_ | 1783716558685601792 |
---|---|
author | Zhang, Hongbin Chai, Siyuan Chen, Lintao Wang, Yubizhuo Cheng, Yongna Fang, Quan Wu, Guosen Wang, Xiangming Liang, Wenjie Xiao, Wenbo |
author_facet | Zhang, Hongbin Chai, Siyuan Chen, Lintao Wang, Yubizhuo Cheng, Yongna Fang, Quan Wu, Guosen Wang, Xiangming Liang, Wenjie Xiao, Wenbo |
author_sort | Zhang, Hongbin |
collection | PubMed |
description | INTRODUCTION: Hepatic sarcomatoid carcinoma (HSC) is a rare type of liver cancer with a high malignant grade and poor prognosis. This study compared the clinical characteristics and magnetic resonance imaging (MRI) features of HSCs with those of hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC), aiming to identify valuable features for HSC diagnosis. METHODS: In total, 17 pathologically confirmed HSC cases, 50 HCC cases and 50 common ICC cases were enrolled from two hospitals. The clinical characteristics and MRI features of all cases were summarized and statistically analyzed. RESULTS: On the one hand, the incidence rates of elevated carbohydrate antigen (CA) 19-9 and elevated carcinoembryonic antigen (CEA) were significantly higher in the HSC cases than in the HCC cases (29.4% vs. 0%; 17.6% vs. 0%). The HSC enhancement patterns, primarily including progressive enhancement, were also significantly different from HCC cases. The incidence rates of heterogeneous signals on T2-weighted imaging and during the arterial phase were significantly higher in the HSC cases than in the HCC cases (94.1% vs. 66.0%; 100.0% vs. 72.0%). The diameter of HSCs was significantly larger than that in the HCC cases (6.12 cm vs. 4.21 cm), and the incidence rates of adjacent cholangiectasis, intrahepatic metastasis and lymph node enlargement were considerably higher in the HSC cases than in the HCC cases (52.9% vs. 6.0%; 47.1% vs. 12.0%; 41.2% vs. 2.0%). On the other hand, the incidence rate of elevated CA199 was significantly lower in the HSC cases than in the ICC cases (29.4% vs. 60.0%). The incidence rates of intratumoral necrosis and pseudocapsules were significantly higher in the HSC cases than in the HCC cases (35.3% vs. 8.0%; 47.1% vs. 12.0%). However, the incidence rates of target signs were significantly lower in the HSC cases than in the HCC cases (11.8% vs. 42.0%). In addition, there was no significant difference in the enhancement patterns between HSC cases and ICC cases. CONCLUSIONS: HSCs were frequently seen in elderly men with clinical symptoms and elevated CA199 levels. The MRI features, including large size, obvious heterogeneity, hemorrhage, progressive enhancement, pseudocapsule and lymph node enlargement, contributed to the diagnosis of HSC. |
format | Online Article Text |
id | pubmed-8247642 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-82476422021-07-02 MRI Features of Hepatic Sarcomatoid Carcinoma Different From Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma Zhang, Hongbin Chai, Siyuan Chen, Lintao Wang, Yubizhuo Cheng, Yongna Fang, Quan Wu, Guosen Wang, Xiangming Liang, Wenjie Xiao, Wenbo Front Oncol Oncology INTRODUCTION: Hepatic sarcomatoid carcinoma (HSC) is a rare type of liver cancer with a high malignant grade and poor prognosis. This study compared the clinical characteristics and magnetic resonance imaging (MRI) features of HSCs with those of hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC), aiming to identify valuable features for HSC diagnosis. METHODS: In total, 17 pathologically confirmed HSC cases, 50 HCC cases and 50 common ICC cases were enrolled from two hospitals. The clinical characteristics and MRI features of all cases were summarized and statistically analyzed. RESULTS: On the one hand, the incidence rates of elevated carbohydrate antigen (CA) 19-9 and elevated carcinoembryonic antigen (CEA) were significantly higher in the HSC cases than in the HCC cases (29.4% vs. 0%; 17.6% vs. 0%). The HSC enhancement patterns, primarily including progressive enhancement, were also significantly different from HCC cases. The incidence rates of heterogeneous signals on T2-weighted imaging and during the arterial phase were significantly higher in the HSC cases than in the HCC cases (94.1% vs. 66.0%; 100.0% vs. 72.0%). The diameter of HSCs was significantly larger than that in the HCC cases (6.12 cm vs. 4.21 cm), and the incidence rates of adjacent cholangiectasis, intrahepatic metastasis and lymph node enlargement were considerably higher in the HSC cases than in the HCC cases (52.9% vs. 6.0%; 47.1% vs. 12.0%; 41.2% vs. 2.0%). On the other hand, the incidence rate of elevated CA199 was significantly lower in the HSC cases than in the ICC cases (29.4% vs. 60.0%). The incidence rates of intratumoral necrosis and pseudocapsules were significantly higher in the HSC cases than in the HCC cases (35.3% vs. 8.0%; 47.1% vs. 12.0%). However, the incidence rates of target signs were significantly lower in the HSC cases than in the HCC cases (11.8% vs. 42.0%). In addition, there was no significant difference in the enhancement patterns between HSC cases and ICC cases. CONCLUSIONS: HSCs were frequently seen in elderly men with clinical symptoms and elevated CA199 levels. The MRI features, including large size, obvious heterogeneity, hemorrhage, progressive enhancement, pseudocapsule and lymph node enlargement, contributed to the diagnosis of HSC. Frontiers Media S.A. 2021-06-17 /pmc/articles/PMC8247642/ /pubmed/34221954 http://dx.doi.org/10.3389/fonc.2021.611738 Text en Copyright © 2021 Zhang, Chai, Chen, Wang, Cheng, Fang, Wu, Wang, Liang and Xiao https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Zhang, Hongbin Chai, Siyuan Chen, Lintao Wang, Yubizhuo Cheng, Yongna Fang, Quan Wu, Guosen Wang, Xiangming Liang, Wenjie Xiao, Wenbo MRI Features of Hepatic Sarcomatoid Carcinoma Different From Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma |
title | MRI Features of Hepatic Sarcomatoid Carcinoma Different From Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma |
title_full | MRI Features of Hepatic Sarcomatoid Carcinoma Different From Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma |
title_fullStr | MRI Features of Hepatic Sarcomatoid Carcinoma Different From Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma |
title_full_unstemmed | MRI Features of Hepatic Sarcomatoid Carcinoma Different From Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma |
title_short | MRI Features of Hepatic Sarcomatoid Carcinoma Different From Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma |
title_sort | mri features of hepatic sarcomatoid carcinoma different from hepatocellular carcinoma and intrahepatic cholangiocarcinoma |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8247642/ https://www.ncbi.nlm.nih.gov/pubmed/34221954 http://dx.doi.org/10.3389/fonc.2021.611738 |
work_keys_str_mv | AT zhanghongbin mrifeaturesofhepaticsarcomatoidcarcinomadifferentfromhepatocellularcarcinomaandintrahepaticcholangiocarcinoma AT chaisiyuan mrifeaturesofhepaticsarcomatoidcarcinomadifferentfromhepatocellularcarcinomaandintrahepaticcholangiocarcinoma AT chenlintao mrifeaturesofhepaticsarcomatoidcarcinomadifferentfromhepatocellularcarcinomaandintrahepaticcholangiocarcinoma AT wangyubizhuo mrifeaturesofhepaticsarcomatoidcarcinomadifferentfromhepatocellularcarcinomaandintrahepaticcholangiocarcinoma AT chengyongna mrifeaturesofhepaticsarcomatoidcarcinomadifferentfromhepatocellularcarcinomaandintrahepaticcholangiocarcinoma AT fangquan mrifeaturesofhepaticsarcomatoidcarcinomadifferentfromhepatocellularcarcinomaandintrahepaticcholangiocarcinoma AT wuguosen mrifeaturesofhepaticsarcomatoidcarcinomadifferentfromhepatocellularcarcinomaandintrahepaticcholangiocarcinoma AT wangxiangming mrifeaturesofhepaticsarcomatoidcarcinomadifferentfromhepatocellularcarcinomaandintrahepaticcholangiocarcinoma AT liangwenjie mrifeaturesofhepaticsarcomatoidcarcinomadifferentfromhepatocellularcarcinomaandintrahepaticcholangiocarcinoma AT xiaowenbo mrifeaturesofhepaticsarcomatoidcarcinomadifferentfromhepatocellularcarcinomaandintrahepaticcholangiocarcinoma |